MK0777

MK0777 · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MK0777, covering 2015-11-26 to 2015-11-26. Get the full timeline:

Most recent: Clinical Trial Update: A Study of MK0777 in the Treatment of Outpatients With Generalized Anxiety Disorder (0777-020) [Phase 2]